HOME › DRUGS › RIMEGEPANT
ACTIVE SUBSTANCE / INN

RIMEGEPANT

Brand name(s): RIMEGEPANT, Vydura
FDA LISTED
EMA LISTED
AUTHORISED
NONE (TENTATIVE APPROVAL)
Migraine Disorders
ANDA219399
ACTIVE SUBSTANCE
Rimegepant
REGULATORS
FDA · EMA
SPONSORS / MAH
APOTEX CORP, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RIMEGEPANTANDA219399APOTEX CORPNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VyduraPfizer Europe MA EEIGAuthorised25/04/2022Migraine Disorders

FULL INTELLIGENCE ON RIMEGEPANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →